The role of bFGF in the excessive activation of astrocytes is related to the inhibition of TLR4/NFκB signals

International Journal of Molecular Sciences

Volumn 17, Issue 1, 2016, Pages

  Ye, Libing ^a   Yang, Ying ^a   Zhang, Xie ^b   Cai, Pingtao ^a   Li, Rui ^a   Chen, Daqing ^a   Wei, Xiaojie ^a   Zhang, Xuesong ^c   Xu, Huazi ^a   Xiao, Jian ^a   Li, Xiaokun ^a   Lin, Li ^a   Zhang, Hongyu ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b Lihuili Hospital   (China)

^c Ningbo Medical Treatment Center Li Huili Hospital   (China)

Author keywords

Astrocytes; bFGF; GFAP; TLR4 NF B; Vimentin

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; NEUROCAN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; VIMENTIN; CYTOKINE; TLR4 PROTEIN, RAT;

ADULT; ANIMAL CELL; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CELL ACTIVATION; CELL CULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOFLUORESCENCE; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; DOWN REGULATION; GENETICS; GLIOSIS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ASTROCYTES; CELLS, CULTURED; CYTOKINES; DOWN-REGULATION; FIBROBLAST GROWTH FACTOR 2; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; NEUROCAN; NF-KAPPA B; RATS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; VIMENTIN;

EID: 84952657925     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17010037     Document Type: Article

References (52)

1. Sofroniew, M.V.; Vinters, H.V. Astrocytes: Biology and pathology. Acta Neuropathol. 2010, 119, 7-35. [CrossRef] [PubMed]
2. Gordon, G.R.; Mulligan, S.J.; MacVicar, B.A. Astrocyte control of the cerebrovasculature. Glia 2007, 55, 1214-1221. [CrossRef] [PubMed]
3. Kawano, H.; Kimura-Kuroda, J.; Komuta, Y.; Yoshioka, N.; Li, H.P.; Kawamura, K.; Li, Y.; Raisman, G. Role of the lesion scar in the response to damage and repair of the central nervous system. Cell Tissue Res. 2012, 349, 169-180. [CrossRef] [PubMed]
4. Hawthorne, A.L.; Hu, H.; Kundu, B.; Steinmetz, M.P.; Wylie, C.J.; Deneris, E.S.; Silver, J. The unusual response of serotonergic neurons after cns injury: Lack of axonal dieback and enhanced sprouting within the inhibitory environment of the glial scar. J. Neurosci. 2011, 31, 5605-5616. [CrossRef] [PubMed]
5. Dharmarajan, S.; Gurel, Z.; Wang, S.; Sorenson, C.M.; Sheibani, N.; Belecky-Adams, T.L. Bone morphogenetic protein 7 regulates reactive gliosis in retinal astrocytes and muller glia. Mol. Vis. 2014, 20, 1085-1108. [PubMed]
6. Kelso, M.L.; Liput, D.J.; Eaves, D.W.; Nixon, K. Upregulated vimentin suggests new areas of neurodegeneration in a model of an alcohol use disorder. Neuroscience 2011, 197, 381-393. [CrossRef] [PubMed]
7. Lee, H.S.; Lee, S.H.; Cha, J.H.; Seo, J.H.; Ahn, B.J.; Kim, K.W. Meteorin is upregulated in reactive astrocytes and functions as a negative feedback effector in reactive gliosis. Mol. Med. Rep. 2015, 12, 1817-1823. [CrossRef] [PubMed]
8. Seo, T.B.; Chang, I.A.; Lee, J.H.; Namgung, U. Beneficial function of cell division cycle 2 activity in astrocytes on axonal regeneration after spinal cord injury. J. Neurotrauma 2013, 30, 1053-1061. [CrossRef] [PubMed]
9. Renault-Mihara, F.; Okada, S.; Shibata, S.; Nakamura, M.; Toyama, Y.; Okano, H. Spinal cord injury: Emerging beneficial role of reactive astrocytes’ migration. Int. J. Biochem. Cell Biol. 2008, 40, 1649-1653. [CrossRef] [PubMed]
10. Herrmann, J.E.; Imura, T.; Song, B.; Qi, J.; Ao, Y.; Nguyen, T.K.; Korsak, R.A.; Takeda, K.; Akira, S.; Sofroniew, M.V. STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J. Neurosci. 2008, 28, 7231-7243. [CrossRef] [PubMed]
11. Pekny, M.; Wilhelmsson, U.; Pekna, M. The dual role of astrocyte activation and reactive gliosis. Neurosci. Lett. 2014, 565, 30-38. [CrossRef] [PubMed]
12. Zhu, Z.; Zhang, Q.; Yu, Z.; Zhang, L.; Tian, D.; Zhu, S.; Bu, B.; Xie, M.; Wang, W. Inhibiting cell cycle progression reduces reactive astrogliosis initiated by scratch injury in vitro and by cerebral ischemia in vivo. Glia 2007, 55, 546-558. [CrossRef] [PubMed]
13. Liu, R.; Wang, Z.; Gou, L.; Xu, H. A cortical astrocyte subpopulation inhibits axon growth in vitro and in vivo. Mol. Med. Rep. 2015, 12, 2598-2606. [CrossRef] [PubMed]
14. Barcia, C.; Ros, C.M.; Annese, V.; Gomez, A.; Ros-Bernal, F.; Aguado-Yera, D.; Martinez-Pagan, M.E.; de Pablos, V.; Fernandez-Villalba, E.; Herrero, M.T. IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of parkinson’s disease. Cell Death Dis. 2011, 2, e142. [CrossRef] [PubMed]
15. Daginakatte, G.C.; Gadzinski, A.; Emnett, R.J.; Stark, J.L.; Gonzales, E.R.; Yan, P.; Lee, J.M.; Cross, A.H.; Gutmann, D.H. Expression profiling identifies a molecular signature of reactive astrocytes stimulated by cyclic amp or proinflammatory cytokines. Exp. Neurol. 2008, 210, 261-267. [CrossRef] [PubMed]
16. Cui, M.; Huang, Y.; Tian, C.; Zhao, Y.; Zheng, J. FOXO3a inhibits TNF-α - and IL-1β-induced astrocyte proliferation:Implication for reactive astrogliosis. Glia 2011, 59, 641-654. [CrossRef] [PubMed]
17. 2+-calmodulin/ERK mitogen-activated protein kinase signaling pathway. Neuroscience 2013, 252, 367-383. [CrossRef] [PubMed]
18. Olajide, O.A.; Bhatia, H.S.; de Oliveira, A.C.; Wright, C.W.; Fiebich, B.L. Inhibition of neuroinflammation in LPS-activated microglia by cryptolepine. Evid. Complement. Altern. Med. 2013, 459723. [CrossRef] [PubMed]
19. Medzhitov, R.; Preston-Hurlburt, P.; Janeway, C.A., Jr. A human homologue of the drosophila toll protein signals activation of adaptive immunity. Nature 1997, 388, 394-397. [PubMed]
20. Wang, Y.; Li, C.; Cheng, K.; Zhang, R.; Narsinh, K.; Li, S.; Li, X.; Qin, X.; Zhang, R.; Li, C., et al. Activation of liver X receptor improves viability of adipose-derived mesenchymal stem cells to attenuate myocardial ischemia injury through TLR4/NF-κB and Keap-1/Nrf-2 signaling pathways. Antioxid. Redox Signal. 2014, 21, 2543-2557. [CrossRef] [PubMed]
21. Proia, P.; Schiera, G.; Mineo, M.; Ingrassia, A.M.; Santoro, G.; Savettieri, G.; di Liegro, I. Astrocytes shed extracellular vesicles that contain fibroblast growth factor-2 and vascular endothelial growth factor. Int. J. Mol. Med. 2008, 21, 63-67. [CrossRef] [PubMed]
22. Shimizu, F.; Sano, Y.; Abe, M.A.; Maeda, T.; Ohtsuki, S.; Terasaki, T.; Kanda, T. Peripheral nerve pericytes modify the blood-nerve barrier function and tight junctional molecules through the secretion of various soluble factors. J. Cell. Physiol. 2011, 226, 255-266. [CrossRef] [PubMed]
23. Jia, Y.; Wu, D.; Zhang, R.; Shuang, W.; Sun, J.; Hao, H.; An, Q.; Liu, Q. Bone marrow-derived mesenchymal stem cells expressing the Shh transgene promotes functional recovery after spinal cord injury in rats. Neurosci. Lett. 2014, 573, 46-51. [CrossRef] [PubMed]
24. DeLeo, J.A.; Colburn, R.W.; Rickman, A.J. Cytokine and growth factor immunohistochemical spinal profiles in two animal models of mononeuropathy. Brain Res. 1997, 759, 50-57. [CrossRef]
25. Xiang, Y.; Liu, H.; Yan, T.; Zhuang, Z.; Jin, D.; Peng, Y. Functional electrical stimulation-facilitated proliferation and regeneration of neural precursor cells in the brains of rats with cerebral infarction. Neural Regen. Res. 2014, 9, 243-251. [PubMed]
26. Rotschafer, J.H.; Hu, S.; Little, M.; Erickson, M.; Low, W.C.; Cheeran, M.C. Modulation of neural stem/progenitor cell proliferation during experimental herpes simplex encephalitis is mediated by differential FGF-2 expression in the adult brain. Neurobiol. Dis. 2013, 58, 144-155. [CrossRef] [PubMed]
27. Gomez-Pinilla, F.; Cummings, B.J.; Cotman, C.W. Induction of basic fibroblast growth factor in Alzheimer’s disease pathology. Neuroreport 1990, 1, 211-214. [CrossRef] [PubMed]
28. Goldshmit, Y.; Frisca, F.; Pinto, A.R.; Pebay, A.; Tang, J.K.; Siegel, A.L.; Kaslin, J.; Currie, P.D. FGF2 improves functional recovery-decreasing gliosis and increasing radial glia and neural progenitor cells after spinal cord injury. Brain Behav. 2014, 4, 187-200. [CrossRef] [PubMed]
29. Reilly, J.F.; Maher, P.A.; Kumari, V.G. Regulation of astrocyte GFAP expression by TGF-α1 and FGF-2. Glia 1998, 22, 202-210. [CrossRef]
30. Kang, W.; Balordi, F.; Su, N.; Chen, L.; Fishell, G.; Hebert, J.M. Astrocyte activation is suppressed in both normal and injured brain by fgf signaling. Proc. Nat. Acad. Sci. USA 2014, 111, E2987-E2995. [CrossRef] [PubMed]
31. Fahmy, G.H.; Moftah, M.Z. FGF-2 in astroglial cells during vertebrate spinal cord recovery. Front. Cell. Neurosci. 2010, 4, 129. [CrossRef] [PubMed]
32. Wu, Y.; Li, W.; Zhou, C.; Lu, F.; Gao, T.; Liu, Y.; Cao, J.; Zhang, Y.; Zhang, Y.; Zhou, C. Ketamine inhibits lipopolysaccharide-induced astrocytes activation by suppressing TLR4/NF-κB pathway. Cell. Physiol. Biochem. 2012, 30, 609-617. [CrossRef] [PubMed]
33. Li, Y.; Zhao, L.; Fu, H.; Wu, Y.; Wang, T. Ulinastatin suppresses lipopolysaccharide induced neuro-inflammation through the downregulation of nuclear factor-κB in SD rat hippocampal astrocyte. Biochem. Biophys. Res. Commun. 2015, 458, 763-770. [CrossRef] [PubMed]
34. Zhang, H.Y.; Zhang, X.; Wang, Z.G.; Shi, H.X.; Wu, F.Z.; Lin, B.B.; Xu, X.L.; Wang, X.J.; Fu, X.B.; Li, Z.Y., et al. Exogenous basic fibroblast growth factor inhibits er stress-induced apoptosis and improves recovery from spinal cord injury. CNS Neurosci. Ther. 2013, 19, 20-29. [CrossRef] [PubMed]
35. Zhang, M.; Ma, Y.F.; Gan, J.X.; Jiang, G.Y.; Xu, S.X.; Tao, X.L.; Hong, A.; Li, J.K. Basic fibroblast growth factor alleviates brain injury following global ischemia reperfusion in rabbits. J. Zhejiang Univ. Sci. B 2005, 6, 637-643. [CrossRef] [PubMed]
36. Gomez-Pinilla, F.; Vu, L.; Cotman, C.W. Regulation of astrocyte proliferation by FGF-2 and heparan sulfate in vivo. J. Neurosci. 1995, 15, 2021-2029. [PubMed]
37. Neary, J.T.; Shi, Y.F.; Kang, Y.; Tran, M.D. Opposing effects of P2X7 and P2Y purine/pyrimidine-preferring receptors on proliferation of astrocytes induced by fibroblast growth factor-2: Implications for CNS development, injury, and repair. J. Neurosci. Res. 2008, 86, 3096-3105. [CrossRef] [PubMed]
38. Lau, L.T.; Yu, A.C. Astrocytes produce and release interleukin-1, interleukin-6, tumor necrosis factor and interferon-γ following traumatic and metabolic injury. J. Neurotrauma 2001, 18, 351-359. [CrossRef] [PubMed]
39. Jeong, S.R.; Kwon, M.J.; Lee, H.G.; Joe, E.H.; Lee, J.H.; Kim, S.S.; Suh-Kim, H.; Kim, B.G. Hepatocyte growth factor reduces astrocytic scar formation and promotes axonal growth beyond glial scars after spinal cord injury. Exp. Neurol. 2012, 233, 312-322. [CrossRef] [PubMed]
40. Fellner, L.; Irschick, R.; Schanda, K.; Reindl, M.; Klimaschewski, L.; Poewe, W.; Wenning, G.K.; Stefanova, N. Toll-like receptor 4 is required for -synuclein dependent activation of microglia and astroglia. Glia 2013, 61, 349-360. [CrossRef] [PubMed]
41. Li, Z.W.; Li, J.J.; Wang, L.; Zhang, J.P.; Wu, J.J.; Mao, X.Q.; Shi, G.F.; Wang, Q.; Wang, F.; Zou, J. Epidermal growth factor receptor inhibitor ameliorates excessive astrogliosis and improves the regeneration microenvironment and functional recovery in adult rats following spinal cord injury. J. Neuroinflamm. 2014, 11, 71. [CrossRef] [PubMed]
42. Yang, F.; Liu, Y.; Tu, J.; Wan, J.; Zhang, J.; Wu, B.; Chen, S.; Zhou, J.; Mu, Y.; Wang, L. Activated astrocytes enhance the dopaminergic differentiation of stem cells and promote brain repair through bFGF. Nat. Commun. 2014, 5, 5627. [CrossRef] [PubMed]
43. Faulkner, J.R.; Herrmann, J.E.; Woo, M.J.; Tansey, K.E.; Doan, N.B.; Sofroniew, M.V. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 2004, 24, 2143-2155. [CrossRef] [PubMed]
44. Liu, Y.; Ye, H.; Satkunendrarajah, K.; Yao, G.S.; Bayon, Y.; Fehlings, M.G. A self-assembling peptide reduces glial scarring, attenuates post-traumatic inflammation and promotes neurological recovery following spinal cord injury. Acta Biomater. 2013, 9, 8075-8088. [CrossRef] [PubMed]
45. Na, J.I.; Na, J.Y.; Choi, W.Y.; Lee, M.C.; Park, M.S.; Choi, K.H.; Lee, J.K.; Kim, K.T.; Park, J.T.; Kim, H.S. The HIF-1 inhibitor YC-1 decreases reactive astrocyte formation in a rodent ischemia model. Am. J. Transl. Res. 2015, 7, 751-760. [PubMed]
46. Tang, X.; Davies, J.E.; Davies, S.J. Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue. J. Neurosci. Res. 2003, 71, 427-444. [CrossRef] [PubMed]
47. Lin, H.W.; Basu, A.; Druckman, C.; Cicchese, M.; Krady, J.K.; Levison, S.W. Astrogliosis is delayed in type 1 interleukin-1 receptor-null mice following a penetrating brain injury. J. Neuroinflamm. 2006, 3, 15. [CrossRef] [PubMed]
48. Aranguez, I.; Torres, C.; Rubio, N. The receptor for tumor necrosis factor on murine astrocytes: Characterization, intracellular degradation, and regulation by cytokines and theiler’s murine encephalomyelitis virus. Glia 1995, 13, 185-194. [CrossRef] [PubMed]
49. Zhang, S.; Qiu, X.; Zhang, Y.; Fu, K.; Zhao, X.; Wu, J.; Hu, Y.; Zhu, W.; Guo, H. Basic fibroblast growth factor ameliorates endothelial dysfunction in radiation-induced bladder injury. Biomed Res. Int. 2015, 2015, 967680. [CrossRef] [PubMed]
50. Yan, B.C.; Park, J.H.; Ahn, J.H.; Kim, I.H.; Lee, J.C.; Yoo, K.Y.; Choi, J.H.; Hwang, I.K.; Cho, J.H.; Kwon, Y.G., et al. Effects of high-fat diet on neuronal damage, gliosis, inflammatory process and oxidative stress in the hippocampus induced by transient cerebral ischemia. Neurochem. Res. 2014, 39, 2465-2478. [CrossRef] [PubMed]
51. 2+-dependent endoplasmic reticulum stress correlates with astrogliosis in oligomeric amyloid β-treated astrocytes and in a model of Alzheimer’s disease. Aging Cell 2013, 12, 292-302. [CrossRef] [PubMed]
52. Kocer, G.; Naziroglu, M.; Celik, O.; Onal, L.; Ozcelik, D.; Kocer, M.; Sonmez, T.T. Basic fibroblast growth factor attenuates bisphosphonate-induced oxidative injury but decreases zinc and copper levels in oral epithelium of rat. Biol. Trace Element Res. 2013, 153, 251-256. [CrossRef] [PubMed]